Invasive pulmonary and central nervous system aspergillosis after near-drowning of a child: Case report and review of the literature

Pediatrics

Volumn 118, Issue 2, 2006, Pages

  Leroy, Piet ^a   Smismans, Annick ^a   Seute, Tatjana ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Central nervous system; Children; Galactomannan; Invasive aspergillosis; Near drowning

Indexed keywords

CASPOFUNGIN; GADOLINIUM; GALACTOMANNAN; ITRACONAZOLE; VORICONAZOLE; FRESH WATER; MANNAN;

ANAMNESIS; ARTICLE; ASPERGILLOSIS; BLOOD EXAMINATION; BRAIN ASPERGILLOSIS; BRAIN BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DROWNING; ECHOCARDIOGRAPHY; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; LABORATORY TEST; LUNG ASPERGILLOSIS; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; ADULT RESPIRATORY DISTRESS SYNDROME; ASPERGILLUS FUMIGATUS; ASPIRATION PNEUMONIA; BACTERIAL PNEUMONIA; BLOOD; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; FATALITY; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; LUNG MYCOSIS; MICROBIOLOGY; NEAR DROWNING; PARAPLEGIA; RESPIRATORY FAILURE; REVIEW; STENOTROPHOMONAS MALTOPHILIA;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DISEASE SUSCEPTIBILITY; EARLY DIAGNOSIS; EPILEPSY; FATAL OUTCOME; FEMALE; FRESH WATER; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; LUNG DISEASES, FUNGAL; MANNANS; NEAR DROWNING; NEUROASPERGILLOSIS; PARAPLEGIA; PNEUMONIA, ASPIRATION; PNEUMONIA, BACTERIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; STENOTROPHOMONAS MALTOPHILIA; WATER MICROBIOLOGY;

EID: 33748434377     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2901     Document Type: Article

References (25)

1. Steinbach WJ. Pediatric aspergillosis: disease and treatment differences in children. Pediatr Infect Dis J. 2005;24:358-364
2. Ender PT, Dolan MJ. Pneumonia after near-drowning. Clin Infect Dis. 1997;25:896-907
3. ter Maaten JC, Golding RP, Strack van Schijndel RJ, Thijs LG. Disseminated aspergillosis after near-drowning. Neth J Med. 1995;47:21-24
4. Kowacs PA, Monteiro de Almeida S, Pinheiro RL, et al. Central nervous system Aspergillus fumigatus infection after near drowning. J Clin Pathol. 2004;57:202-204
5. Suominen P, Baillie C, Korpela R, Rautanen S, Ranta S, Olkkola KT. Impact of age, submersion time and water temperature on outcome in near-drowning. Resuscitation. 2002;52:247-254
6. Crowe S, Mannion D, Healy M, O'Hare B, Lyons B. Paediatric near-drowning: mortality and outcome in a temperate climate. Ir Med J. 2003;96:274-276
7. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32:358-366
8. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration. 1995;62:341-347
9. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985;157:611-614
10. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis. 2002;186:1297-1306
11. Mennink-Kersten MA, Klont RR, Warris A, Op den Camp HJ, Verweij PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection. Lancet. 2004;363:325-327
12. Warris A, Abrahamsen TG, Breuker IM, Meis JF, Gaustad P, Verweij PE. Fungal antigenemia in premature neonates due to the presence of galactomannan and mannan in milk formulas [abstract]. Presented at: 41st annual Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, IL; December16-19, 2001. Abstract J-848
13. Singh N, Obman A, Husain S, Aspinall S, Mietzner S, Stout JE. Reactivity of platelia Aspergillus galactomannan antigen with piperacillin- tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother. 2004;48:1989-1992
14. Maertens J, Theunissen K, Verhoef G, Van Eldere J. False-positive Aspergillus galactomannan antigen test results. Clin Infect Dis. 2004;39:289-290
15. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leiba C, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care. 2005;9:R191-R199
16. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33:1824-1833
17. Palanisamy A, Chao SD, Fouts M, Kerr D. Central nervous system aspergillosis in an immunocompetent patient: cure in a hospice setting with very high-dose itraconazole. Am J Hosp Palliat Care. 2005;22:139-144
18. Tattevin P, Bruneel F, Lellouche F, et al. Successful treatment of brain aspergillosis with voriconazole. Clin Microbiol Infect. 2004;10:928-931
19. Schwartz S, Ruhnke M, Ribaud P, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood. 2005;106:2641-2645
20. Schwartz S, Thiel E. Update on the treatment of cerebral aspergillosis. Ann Hematol. 2004;83(suppl 1):S42-S44
21. Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis, and other invasive fungal infections in children. Pediatr Infect Dis J. 2002;21:240-248
22. Clemons KV, Espiritu M, Parmar R, Stevens DA. Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob Agents Chemother. 2005;49:4867-4875
23. Cancidas (caspofungin acetate) for injection [package insert]. Whitehouse Station, NJ: Merck & Co, Inc; 2004. Available at: www.fda.gov/MedWatch/ SAFETY/2004/mar_PI/Cancidas_PI.pdf. Accessed December 1, 2003
24. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis. 2004;39:797-302
25. Pfaller MA, Marco F, Messer SA, Jones RN. In vitro activity of two echinocanin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis. 1998;30:251-255